FDA Inspection 995551 — Molecular NeuroImaging, LLC
The FDA completed an inspection of Molecular NeuroImaging, LLC on Dec 2, 2016 in New Haven, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 2, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Haven, CT (United States)
Additional Details
Sponsor, Contract Research Organization